*Based on data released by the Federal Election Commission on October 05, 2024 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...

Shares of recently debuted nursing home operator, PACS Group Inc., plunged this week in a sharp reversal that erased around $2.5 billion from its cofounders’ fortunes. It started on Monday when ...

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

PACS shares fell as much as 30% after the release ... $3.32 billion for Cendant investors, $1.05 billion for McKesson investors, and $970.5 million for AIG investors. We sell different types ...

McKesson (MCK) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Research shows that stocks ...

Famed short-seller research group Hindenburg Research dropped another bomb this afternoon. PACS Group (PACS) was the target today and boy was the report a doozy. PACS went public back in April in ...

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target remains the same with $535.00. Steve Baxter’s rating is ...

The latest trading session saw McKesson (MCK) ending at $513.67, denoting a +0.86% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.76%.